Improved management of patients with urinary catheters through the implementation of high standards in infection prevention and control remains central to minimising the risk of infection. Recent excellent work has been done in the NHS on reducing unnecessary use of catheters, reducing the need for antibiotics and limiting the emergence and spread of multi-drug resistant organisms. For patients who require long term catheterisation, a breakthrough ultrasound-based product has been designed to prevent bacterial colonisation and biofilm on indwelling urinary catheters and increase antibiotic efficacy, ultimately reducing the incidence of catheter-associated urinary tract infections. This ultrasound device has been successfully clinically studied and the results of the most recent study are being presented today.
Benefits of Attending
Hear how the use of this unique ultrasound device can further improve the management of patients with Urinary Catheters in the NHS and UK Healthcare by producing changes in the following:
• Reduction in CAUTI
• Reduction in prescribing and consumption of antimicrobials
• Reduction in resistant organisms
• Reduction in pain associated with CAUTI
• Better patient outcomes Contribute to the discussion on how this could be introduced to the UK healthcare system
• Presentation of a clinical study on a unique ultrasound-based medical device
• Discover how using ultrasound device reduces CAUTIs
• Discuss how the device has potential to help achieve NHS objectives such as reducing the use of antibiotics, lowering infection rates, decreasing hospital admissions and improving patient safety.
• Find out how to arrange an evaluation of the device.
Dr. Jacob is board certified in Internal Medicine and Gastroenterology and a member of the American College of Medicine and American Gastroenterological Association (AGA) and a Fellow of the American College of Gastroenterology (ACG). He founded and served as Editor in Chief of Endoscopy Review and has authored numerous publications in the field of gastroenterology. Dr. Jacob has served as an attending physician at Hadassah University Medical Center and was the Director of the Gastrointestinal Endoscopy Unit. He served as Co-Chief of Gastroenterology at St. John’s Episcopal Hospital in New York, Clinical Assistant Professor of Medicine at SUNY Brooklyn and Chief of Gastro at South Nassau Communities Hospital, Oceanside, New York. He is also part time attending in Gastroenterology at Bikur Cholim Hospital in Israel. He has patented and licensed a number of medical devices in daily hospital use today.
Chairman Dr Chris Ogden, Consultant Urological Surgeon. Dr Ogden Chris Ogden was the first UK urologist to present a peer reviewed paper at the national congress BAUS on 100 consecutive robotic prostate operations with full oncological and functional outcomes. His paper on his long term results of robotic prostate surgery was accepted and presented at the American Urological Association (AUA) Congress Meeting and awarded the prize for best paper. He is the first urologist in the world to compare consecutive cases of the ground breaking technologies of HIFU (High Intensity Focused Ultrasound) and robotics, presenting at the UK annual conference. He has been a part of the development of Focal day case surgery for treating certain forms of prostate cancer, completing the multi centre INDEX study into the effectiveness of focal therapy.